HOLX insider trading
HealthcareHOLOGIC INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About HOLOGIC INC
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analysis software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology systems; and breast conserving surgery products. In addition, the company provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system. The company sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Company website: www.hologic.com
HOLX insider activity at a glance
FilingIQ has scored 1,079 insider transactions for HOLX since Jan 27, 2015. The most recent filing in our index is dated Apr 7, 2026.
Across the full history, 4 open-market purchases
and 142 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on HOLX insider trades is 64.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest HOLX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for HOLX?
- FilingIQ tracks 1,079 Form 4 insider transactions for HOLX (HOLOGIC INC), covering filings from Jan 27, 2015 onwards. 151 of those were filed in the last 90 days.
- Are HOLX insiders net buyers or net sellers?
- Across the full Form 4 history for HOLX, 4 transactions (0%) were open-market purchases and 142 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does HOLX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is HOLX in?
- HOLOGIC INC (HOLX) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $16.77B.
Methodology & sources
Every HOLX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.